Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports
{{output}}
Immune checkpoint inhibitors (ICIs) are clinically used for treating advanced lung cancer, and some patients have achieved complete remission (CR) with ICI therapy in clinical trials. However, reports summarizing the clinical courses of such patients are limit... ...
